The Medication Experience Study

NCT01702883 | Completed

• 1 other identifier: IRB00020789
• Study Type: interventional
• Target: 186
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to evaluate whether participation in an Internet-based intervention helps improve medication use.

Conditions

Hypertension; Elevated Cholesterol; Diabetes; Depression

Keywords

prescriptions; hypertension; high cholesterol; diabetes; depression; adherence

Outcome Measures

Primary Outcomes (1)

• The primary measure will be adherence as measured by pharmacy refills in each group.

  12 months

Study Arms (4)

Control

NO INTERVENTION

Randomization occurs after enrollment survey has been completed. This group will not receive the internet intervention for the twelve months. They will be asked to complete the final survey.

Intervention Group A

EXPERIMENTAL

Randomization occurs after enrollment survey has been completed. Upon secondary randomization at week eight, this group will continue to receive weekly internet surveys for the entire twelve months. They will be asked to complete the final survey.

Other: Internet Survey

Intervention Group B

EXPERIMENTAL

Randomization occurs after enrollment survey has been completed. This group will complete weekly internet surveys for eight weeks. Upon secondary randomization at week eight, this group will begin to receive monthly internet surveys. They will be asked to complete the final survey.

Other: Internet Survey

Intervention Group C

EXPERIMENTAL

Randomization occurs after enrollment survey has been completed. This group will complete weekly internet surveys for eight weeks. Upon secondary randomization at week eight, the group will not receive any more internet surveys. They will be asked to complete the final survey.

Other: Internet Survey

Interventions

Internet Survey OTHER

prompt to complete internet survey

Also known as: internet surveys

Intervention Group A; Intervention Group B; Intervention Group C

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Any male or female 18 years or older, filling prescriptions for oral medications for hypertension, high cholesterol, diabetes, or depression at the Downtown Health Plaza, Piedmont Plaza, or Cancer Center Pharmacies.

You may not qualify if:

• Inability to complete Internet surveys due to inadequate Internet access, not understanding a survey written in English, or lack of computer skills.
• Patient does not intend to continue using the same WFBMC-affiliated pharmacy for the next 12 months.

Sponsors & Collaborators

• Wake Forest University: lead

Study Sites (1)

Wake Forest University Health Sciences

Winston-Salem, North Carolina, 27157, United States

Location

MeSH Terms

Conditions

Hypertension; Hypercholesterolemia; Diabetes Mellitus; Depression

Condition Hierarchy (Ancestors)

Vascular Diseases; Cardiovascular Diseases; Hyperlipidemias; Dyslipidemias; Lipid Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Glucose Metabolism Disorders; Endocrine System Diseases; Behavioral Symptoms; Behavior

Study Officials

• Steve R Feldman, MD, PhD

  Wake Forest University Health Sciences

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, INVESTIGATOR
• Purpose: OTHER
• Intervention Model: FACTORIAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 4, 2012
• First Posted: October 10, 2012
• Study Start: October 1, 2012
• Primary Completion: July 31, 2015
• Study Completion: May 11, 2021
• Last Updated: July 3, 2025

Record last verified: 2025-04

Locations

US (1)